High Tower Advisors, LLC Chembio Diagnostics, Inc. Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.09 - $2.55 $218 - $509	-200 Reduced 0.94%	21,012 $24,000
Q3 2021 Nov 12, 2021	BUY	$2.06 - $5.34 $6,616 - $17,152	3,212 Added 17.84%	21,212 $54,000
Q1 2021 May 10, 2021	SELL	$3.4 - $7.97 $120,839 - $283,261	-35,541 Reduced 66.38%	18,000 $63,000
Q4 2020 Feb 10, 2021	BUY	$4.11 - $7.51 $33,960 - $62,055	8,263 Added 18.25%	53,541 $255,000
Q2 2020 Aug 10, 2020	BUY	$3.18 - $15.54 $36,452 - $178,135	11,463 Added 33.9%	45,278 $148,000
Q4 2019 Feb 14, 2020	BUY	$3.94 - $5.76 $74,860 - $109,440	19,000 Added 128.25%	33,815 $155,000
Q2 2019 Aug 13, 2019	BUY	$5.56 - $7.85 $82,371 - $116,297	14,815 New	14,815 $90,000
Q4 2018 Feb 14, 2019	SELL	$4.95 - $10.5 $68,715 - $145,761	-13,882 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$9.2 - $11.5 $127,714 - $159,643	13,882 New	13,882 $145,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.